Cargando…
Indicators of responsiveness to immune checkpoint inhibitors
Modulation of the immune system can produce anti-tumor responses in various cancer types, including melanoma. Recently, immune checkpoint inhibitors (ICI), in single agent and combination regimens, have produced durable and long-lasting clinical responses in a subset of metastatic melanoma patients....
Autores principales: | Shields, Bradley D., Mahmoud, Fade, Taylor, Erin M., Byrum, Stephanie D., Sengupta, Deepanwita, Koss, Brian, Baldini, Giulia, Ransom, Seth, Cline, Kyle, Mackintosh, Samuel G., Edmondson, Ricky D., Shalin, Sara, Tackett, Alan J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429745/ https://www.ncbi.nlm.nih.gov/pubmed/28400597 http://dx.doi.org/10.1038/s41598-017-01000-2 |
Ejemplares similares
-
Proteomics and melanoma: a current perspective
por: Shields, Bradley D, et al.
Publicado: (2016) -
Label-Free Proteomic
Approach to Characterize Protease-Dependent
and -Independent Effects of sarA Inactivation on
the Staphylococcus aureus Exoproteome
por: Byrum, Stephanie D., et al.
Publicado: (2018) -
Microscopes and Mass Spectrometers
por: Shields, Bradley, et al.
Publicado: (2016) -
Proteogenomic analysis of melanoma brain metastases from distinct anatomical sites identifies pathways of metastatic progression
por: Taylor, Erin M., et al.
Publicado: (2020) -
A conserved BAH module within mammalian BAHD1 connects H3K27me3 to Polycomb gene silencing
por: Fan, Huitao, et al.
Publicado: (2021)